MedPath

The Clinical Evaluation of Two Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: etafilcon A
Device: omafilcon A
Registration Number
NCT00762996
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • They are of legal age (18 years) and capacity to volunteer.
  • They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They would be expected to attain at least 6.9 (20/30) in each eye with the study lenses.
  • They are able to wear contact lenses which have a back vertex power of -1.00 to -6.00DS.
  • They have a maximum of 1.00D of refractive astigmatism (i.e. < 1.00 DC).
  • They have worn soft contact lenses within six months of starting the study.
Exclusion Criteria
  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
  • They are pregnant or lactating.
  • They have grade 2 or greater of any of the following ocular surface signs: corneal edema, corneal vascularization, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  • They have any infectious disease (e.g., hepatitis) or any immunosuppressive disease (e.g., HIV).
  • They have diabetes.
  • They are currently taking part in any other clinical study or research.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
etafilcon A/omafilcon Aetafilcon APeriod 1: etafilcon A, Period 2: omafilcon A
etafilcon A/omafilcon Aomafilcon APeriod 1: etafilcon A, Period 2: omafilcon A
omafilcon A/etafilcon Aetafilcon APeriod 1: omafilcon A, Period 2: etafilcon A
omafilcon A/omafilcon Aomafilcon APeriod 1: omafilcon A, Period 2: omafilcon A
etafilcon A/etafilcon Aetafilcon APeriod 1: etafilcon A, Period 2: etafilcon A
omafilcon A/etafilcon Aomafilcon APeriod 1: omafilcon A, Period 2: etafilcon A
Primary Outcome Measures
NameTimeMethod
Distance Visual Acuity1 week

logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

Secondary Outcome Measures
NameTimeMethod
Lens Comfort1 week

A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control.\>0 = comfortable, \<0 = uncomfortable

Trial Locations

Locations (1)

Eurolens Research

🇬🇧

Manchester, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath